ly 255283 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 3 studies
| Studies (ly 255283) | Trials (ly 255283) | Recent Studies (post-2010) (ly 255283) | Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) |
|---|---|---|---|---|---|
| 54 | 0 | 15 | 9,156 | 187 | 552 |
| Protein | Taxonomy | ly 255283 (IC50) | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donigi-Gale, D; Edwards, R; Norman, KE; Rossi, AG; Shoupe, TS; Williams, TJ | 1 |
| Au, BT; Collins, PD; Williams, TJ | 1 |
| Anderson, R; Steel, HC; Theron, AJ; Tintinger, GR | 1 |
3 other study(ies) available for ly 255283 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.
Topics: Animals; Arthus Reaction; Azepines; Complement System Proteins; Edema; Isoquinolines; Leukotriene B4; Platelet Activating Factor; Rabbits; Radioimmunoassay; Receptors, Complement; Tetrazoles; Triazoles; Zymosan | 1992 |
Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator.
Topics: Antibodies, Monoclonal; Calcimycin; CD18 Antigens; Humans; Integrins; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Sialoglycoproteins; Tetrazoles; Tumor Necrosis Factor-alpha; Zymosan | 1994 |
Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4.
Topics: Adenosine Triphosphate; Antifungal Agents; Calcium; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Humans; Indoles; Itraconazole; Leukotriene Antagonists; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Spectrometry, Fluorescence; Tetrazoles | 2007 |